Regulatory News Service Feed

Headline
Date
Download
PDMR Shareholding/SIP & Total Voting Rights
April 01, 2026 11:59
PDMR Shareholding/Share Incentive Plan and TVRs
March 03, 2026 10:56
PDMR Shareholding/Share Incentive Plan & TVR
February 03, 2026 08:01
Full Year 2025 Trading Update
January 15, 2026 07:00
PDMR Shareholding/SIP & Total Voting Rights
December 23, 2025 07:00
PDMR Shareholding/SIP & Total Voting Rights
November 28, 2025 11:53
PDMR Shareholding/Share Incentive Plan and TVR
November 04, 2025 07:00
Block listing Interim Review
October 07, 2025 07:00
PDMR Shareholding/Share Incentive Plan and TVR
October 01, 2025 11:40
H1 2025 Results
September 23, 2025 07:00
Notice of Results
September 11, 2025 07:00
Holding(s) in Company
September 09, 2025 10:47
PDMR Shareholding/Share Incentive Plan and TVR
September 02, 2025 07:00
Holding(s) in Company
August 11, 2025 10:58
Diaceutics at Canaccord Genuity Growth Conference
August 05, 2025 07:00
PDMR Shareholding/Share Incentive Plan and TVR
July 30, 2025 07:00
Diaceutics Announces Key Leadership Appointment
July 29, 2025 07:00
Holding(s) in Company
July 25, 2025 12:15
Issue of Share Options / PDMR Shareholdings
July 23, 2025 07:00
22% Revenue Growth H125 representing 3-yr CAGR 25%
July 22, 2025 07:00
Expansion of PMx Commercialization Partnership
July 17, 2025 07:00
PDMR Shareholding/SIP and Total Voting Rights
June 30, 2025 07:00
Results of AGM
June 18, 2025 12:00
PDMR Shareholding /Share Incentive Plan and TVR
June 06, 2025 09:33
Notice of AGM and Posting of Annual Report
May 21, 2025 17:00
Transaction by Persons Closely Associated to PDMRs
May 15, 2025 07:00
FY 2024 Results - Strong Revenue Growth
May 13, 2025 07:00
PDMR Shareholding/Share Incentive Plan and TVR
April 29, 2025 16:09
Notice of Results
April 29, 2025 07:00
Block Listing Return
April 07, 2025 10:33
PDMR Shareholding/Share Incentive Plan and TVR
April 03, 2025 13:54
PMx Promotional Partner Contract Enhancement
March 26, 2025 07:00
Holding(s) in Company
March 06, 2025 15:16
PDMR Shareholding/Share Incentive Plan and TVR
March 03, 2025 15:00
Purchase of Shares and PDMR Shareholding
January 31, 2025 09:13
PDMR Shareholding/Share Incentive Plan
January 30, 2025 11:27
FY 2024 Trading Update - Strong Revenue Growth
January 28, 2025 07:00
Diaceutics Opens US Headquarters
January 14, 2025 07:00
New Service Launched & First Contract Signed
January 08, 2025 07:00
PDMR Dealings & Total Voting Rights
January 03, 2025 15:39
Holding(s) in Company
December 19, 2024 08:09
Holding(s) in Company
December 17, 2024 10:46
Diaceutics Wins New $5.1m Contract
December 17, 2024 07:00
Holding(s) in Company
December 10, 2024 15:14
Awarded UK Research Institute Grant Funding of £1m
December 05, 2024 07:00
Total Voting Rights
December 03, 2024 14:24
Expansion of US Commercial Activities
November 28, 2024 07:00
Capital Markets Webinar
November 05, 2024 07:00
Holding(s) in Company
November 04, 2024 07:00
PDMR Shareholding/Share Incentive Plan
October 30, 2024 14:58
Board Change Update
October 29, 2024 10:27
Issue of Share Options/PDMR Shareholdings
October 25, 2024 07:00
Cancellation of Share Premium Account
October 24, 2024 12:53
Diaceutics Announces Key Leadership Appointment
October 15, 2024 07:00
Holding(s) in Company
October 07, 2024 13:19
Block Listing Return
October 07, 2024 07:00
PDMR Shareholding/Share Incentive Plan
October 02, 2024 07:00
Board Changes
October 01, 2024 07:00
H1 2024 Results - Continued Performance & Growth
September 17, 2024 07:00
Notice of Results & Presentations
September 09, 2024 07:00
Appointment of Nominated Adviser and Broker
September 02, 2024 07:00
PDMR Shareholding/Share Incentive Plan
August 30, 2024 15:45
Diaceutics Launches Enhanced Rare-Disease Offering
August 27, 2024 07:00
Enterprise Partnership and Launch of PMx
August 19, 2024 07:00
Presenting at Canaccord Genuity Growth Conference
August 05, 2024 07:00
PDMR Shareholding/SIP and TVR
July 29, 2024 18:09
Issue of Share Options/PDMR Shareholdings
July 29, 2024 07:00
Board Changes
July 23, 2024 07:05
Revenue growth of 24% in H1 with 55% now recurring
July 23, 2024 07:00
Senior Management Appointments
July 11, 2024 07:00
PDMR Shareholding/SIP and Total Voting Rights
July 01, 2024 07:00
Result of AGM
June 24, 2024 13:15
"Precision Medicine in Oncology " Virtual Event
June 13, 2024 07:00
Diaceutics - Capital Markets Event
June 06, 2024 07:00
Notice of AGM and Posting of Annual Report
May 29, 2024 08:00
Data to be Presented at 2024 ASCO Annual Meeting
May 28, 2024 07:00
PDMR Shareholding/SIP and Total Voting Rights
May 24, 2024 15:01
Director / PDMR Shareholding
May 23, 2024 07:00
Revenue growth of 22% & order book growth of 57%
May 21, 2024 07:00
Two New Enterprise-Wide Engagements
May 16, 2024 07:00
Diaceutics - Capital Markets Event
May 14, 2024 07:00
Notice of Results & Presentations
May 01, 2024 07:00
PDMR Shareholding/SIP and TVR
April 30, 2024 07:00
Appointment of Amie Mc Neice as VP of Marketing
April 09, 2024 07:00
Block Listing Return
April 05, 2024 13:40
PDMR Shareholding/Share Incentive Plan
April 03, 2024 07:00
Director/PDMR/PCA Shareholding & TR1
April 02, 2024 07:00
Significant upgrade to Diaceutics' DXRX platform
March 21, 2024 07:00
Diaceutics forms landmark industry Forum
March 19, 2024 07:00
Director/PDMR Shareholding
March 07, 2024 07:00
PDMR Shareholding / SIP and TVR
March 01, 2024 09:00
Expanded lab network and data capabilities
February 27, 2024 07:00
Diaceutics PLC - Strategic alliance with KPMG
February 14, 2024 13:00
Appointment of VP, Scientific & Medical Services
February 05, 2024 07:00
PDMR Shareholding/Share Incentive Plan and TVR
February 01, 2024 12:31
Diaceutics PLC – Trading Update
January 30, 2024 07:00
Exercise of Warrant & Total Voting Rights
January 25, 2024 13:16
Diaceutics PLC – Financial Calendar Update
January 19, 2024 07:00
PDMR Shareholding/Share Incentive Plan
December 29, 2023 13:18
PDMR Shareholding/Share Incentive Plan and TVR
November 30, 2023 12:59
Diaceutics to attend Stifel Conference in NYC
November 30, 2023 07:00
Notification of Major Holdings
November 21, 2023 11:13
PDMR Shareholding/SIP & Total Voting Rights
October 31, 2023 12:38
PDMR Shareholding/Share Incentive Plan and TVR
October 11, 2023 13:47
Block Listing Application to AIM
October 02, 2023 15:59
Holding(s) in Company
September 29, 2023 11:19
Diaceutics PLC - Planned CEO Transition
September 26, 2023 07:00
Diaceutics PLC – Half Year Results
September 26, 2023 07:00
Diaceutics PLC – Directorate Changes
September 21, 2023 14:37
Attending 10th Annual HealthTech Investment Forum
September 07, 2023 07:00
Notice of Interim Results and Presentations
September 05, 2023 07:00
PDMR Shareholding/Share Incentive Plan
August 30, 2023 14:56
Diaceutics launches daily alerts for DXRX platform
August 29, 2023 07:00
Canaccord Genuity 43rd Annual Growth Conference
August 04, 2023 07:00
PDMR Shareholding/Share Incentive Plan
July 31, 2023 15:19
Trading Update and Notice of Results
July 25, 2023 07:00
PDMR Shareholding/Share Incentive Plan
June 29, 2023 12:07
Purchase and Sale of Shares and PDMR Shareholdings
June 06, 2023 07:00
USD 10.1 million multi-year enterprise engagement
June 05, 2023 07:00
PDMR Shareholding/Share Incentive Plan
May 31, 2023 17:13
Issue of Share Options/PDMR Shareholdings
May 19, 2023 10:16
Results of Annual General Meeting
May 18, 2023 11:46
PDMR Shareholdings
May 11, 2023 18:22
PDMR shareholdings
May 04, 2023 10:34
PDMR Shareholding/Share Incentive Plan
April 28, 2023 18:03
PDMR Shareholding
April 26, 2023 17:03
Notice of AGM and Posting of Annual Report
April 25, 2023 17:45
Final Results
April 17, 2023 07:00
PDMR Shareholding / Share Incentive Plan
April 03, 2023 14:43
Notice of Results and Presentations
March 20, 2023 07:00
Restoration - Diaceutics PLC
March 13, 2023 10:15
Further update regarding Silicon Valley Bank
March 13, 2023 10:12
Suspension - Diaceutics PLC
March 13, 2023 07:30
Update regarding Silicon Valley Bank
March 13, 2023 07:00
PDMR Shareholding/Share Incentive Plan
March 01, 2023 13:57
PDMR Shareholding/Share Incentive Plan
January 30, 2023 17:11
USD 7m enterprise engagements for data services
January 26, 2023 07:00
Trading Statement and Strategy Update
January 26, 2023 07:00
PDMR Shareholding/Share Incentive Plan
January 03, 2023 07:00
Change of Auditor
November 29, 2022 07:00
PDMR Shareholding/Share Incentive Plan
November 29, 2022 07:00
Sub-optimal testing impacts on cancer patients
November 01, 2022 07:00
PDMR Shareholding/Share Incentive Plan
October 31, 2022 14:20
PDMR Shareholding/Share Incentive Plan
October 05, 2022 17:03
Purchase of Shares and PDMR Shareholding
October 05, 2022 07:00
Half-year Report
September 27, 2022 07:00
PDMR Shareholding/Share Incentive Plan
September 12, 2022 12:38
Notice of Results and Presentations
September 08, 2022 07:00
PDMR Shareholding/Share Incentive Plan
August 08, 2022 07:00
Trading Update and Notice of Results
July 26, 2022 07:00
PDMR Shareholding/Share Incentive Plan
July 22, 2022 17:45
Multi-year contract with top five global pharma
June 13, 2022 07:00
New AI and ML Capabilities Enhance DXRX Platform
June 07, 2022 07:00
PDMR Shareholding/Share Incentive Plan
May 31, 2022 12:12
Share Options and PDMR Shareholdings
May 27, 2022 16:31
Result of AGM
May 26, 2022 15:00
PDMR Shareholding/Share Incentive Plan
May 11, 2022 14:34
Exercise of Warrant & Total Voting Rights
May 09, 2022 16:37
Contract Win
May 05, 2022 07:00
PDMR Shareholding/Share Incentive Plan
April 29, 2022 17:22
Notice of AGM and Posting of Annual Report
April 28, 2022 14:09
Purchase and Sale of Shares and PDMR Shareholdings
April 07, 2022 07:00
PDMR Shareholding/Share Incentive Plan
April 06, 2022 13:13
Conversion of Convertible Loan Notes & TVR
April 05, 2022 15:49
Issue of Share Options / PDMR Shareholdings
April 01, 2022 07:00
PDMR Shareholding/Share Incentive Plan
March 31, 2022 17:38
Final Results
March 22, 2022 14:43
Notice of 2021 Full Year Results
March 22, 2022 07:00
Confirmation of Directorate Change
March 18, 2022 14:09
Holding(s) in Company
March 16, 2022 17:49
Approval by CMS for enhanced data access
March 16, 2022 07:00
PDMR Shareholding/Share Incentive Plan
March 02, 2022 17:37
Investor Presentation
February 21, 2022 07:00
PDMR Shareholding/Share Incentive Plan
February 14, 2022 18:26
Contract with leading life sciences company
February 14, 2022 07:00
Director/PDMR Shareholding
February 04, 2022 11:26
Directorate Change
January 11, 2022 07:01
Trading Update and Notice of Results
January 11, 2022 07:00
PDMR Shareholding/Share Incentive Plan
January 04, 2022 07:00
Contract Win
December 14, 2021 07:00
Test Signal Launch and Contract Wins
December 09, 2021 07:00
PDMR Shareholding/Share Incentive Plan
December 01, 2021 17:22
PDMR Shareholding/Share Incentive Plan
November 09, 2021 16:57
PDMR Shareholding/Share Incentive Plan
October 01, 2021 13:19
Holding(s) in Company
October 01, 2021 12:32
Purchase/Transfer of Shares and PDMR Shareholdings
September 28, 2021 07:00
Nominated as finalists for Health Tech Awards 2021
September 21, 2021 07:00
Half-year Report
September 14, 2021 07:00
DXRX Platform Contract Win
September 13, 2021 07:00
Two new experts join the Diaceutics Advisory Panel
September 08, 2021 07:00
PDMR Shareholding/Share Incentive Plan
September 01, 2021 07:00
Notice of Investor Presentation
August 31, 2021 07:00
PDMR Shareholding/Share Incentive Plan
July 30, 2021 16:54
Trading Update
July 08, 2021 07:00
Issue of Share Options and PDMR Shareholdings
July 01, 2021 07:00
PDMR Shareholding/Share Incentive Plan
June 29, 2021 16:56
New Contract Wins
June 24, 2021 07:00
Purchase of Shares and PDMR Shareholding
June 18, 2021 07:00
Capital Markets Day and KPI Update
June 16, 2021 07:00
PDMR Shareholding/Share Incentive Plan
June 07, 2021 18:23
Notice of Capital Markets Day
June 07, 2021 07:00
Presenting data on COVID impact on cancer at ASCO
June 04, 2021 07:00
Holding(s) in Company
May 21, 2021 13:49
Change of Adviser
May 21, 2021 07:00
Result of AGM
May 19, 2021 15:24
LGC SeraCare Partnership
May 13, 2021 07:00
Sale of Shares and PDMR Shareholding
May 12, 2021 17:58
Holding(s) in Company
May 05, 2021 18:03
Sale of Shares and Director/PDMR Shareholding
May 04, 2021 15:11
Share Incentive Plan
April 30, 2021 11:01
Notice of AGM and posting of Annual Report
April 21, 2021 07:00
New Vice President of Operations in Asia
April 12, 2021 07:00
Transfer of Shares and Director/PDMR Shareholding
April 08, 2021 09:49
Transfer of Shares and Director/PDMR Shareholding
April 07, 2021 07:58
Issue of Share Options/PDMR Shareholdings
April 06, 2021 11:12
COVID-19 Testing Data licensing agreement
April 01, 2021 07:00
New lease agreement and related party transaction
March 30, 2021 07:00
Final Results
March 15, 2021 07:00
Notice of Results
March 08, 2021 07:00
New Vice President of Finance appointment
March 04, 2021 12:49
Quarterly media update
January 21, 2021 07:00
Holding(s) in Company
January 11, 2021 09:56
Trading update
January 11, 2021 07:00
Directorate Change
December 22, 2020 07:01
Directorate Change
December 22, 2020 07:00
Holding(s) in Company
December 10, 2020 15:10
European international award win
November 17, 2020 07:00
Holding(s) in Company
November 10, 2020 16:32
Commercial launch of DXRX
October 28, 2020 07:00
Second Price Monitoring Extn
September 07, 2020 14:05
Price Monitoring Extension
September 07, 2020 14:00
Price Monitoring Extension
September 07, 2020 11:00
Half-year Report
September 07, 2020 07:00
Notice of Results
August 27, 2020 07:00
New contract win for DXRX platform
July 22, 2020 07:00
Holding(s) in Company
July 09, 2020 07:00
Trading update
July 08, 2020 07:00
Second Price Monitoring Extn
July 06, 2020 16:41
Price Monitoring Extension
July 06, 2020 16:36
Holding(s) in Company
July 03, 2020 10:43
Issue of Share Options
July 03, 2020 07:00
Result of General Meeting
June 29, 2020 14:55
Holding(s) in Company
June 19, 2020 07:00
Exercise of warrant
June 11, 2020 14:00
Placing of £20.5 million
June 11, 2020 07:00
Result of AGM
May 19, 2020 14:29
AGM Statement
May 19, 2020 07:00
Diagnostic network for precision medicine update
May 18, 2020 07:00
Cancer testing & diagnosis suffers sharp downturn
April 29, 2020 07:00
Posting of Annual Report and Notice of AGM
April 23, 2020 07:00
Issue of Share Options
April 06, 2020 07:00
Belfast investor presentation
March 19, 2020 07:00
Second Price Monitoring Extn
March 17, 2020 09:05
Price Monitoring Extension
March 17, 2020 09:00
Second Price Monitoring Extn
March 16, 2020 11:05
Price Monitoring Extension
March 16, 2020 11:00
Final Results
March 16, 2020 07:00
Private investor briefing
March 12, 2020 14:24
Notice of Results
February 27, 2020 07:00
Belfast investor presentation
February 17, 2020 07:00
Growth & Innovation Forum 2020
February 06, 2020 07:00
Holding(s) in Company
January 17, 2020 14:53
Second Price Monitoring Extn
January 13, 2020 09:05
Price Monitoring Extension
January 13, 2020 09:00
Year-End Trading Update
January 13, 2020 07:00
Presentation at AICon 2019
November 25, 2019 07:00
Presentation at Big Data Belfast
October 24, 2019 07:00
Pharma Precision Medicine Readiness Report
October 21, 2019 07:00
Workshop presentation at EORTC
October 10, 2019 07:00
Poster presentation at ESMO
September 30, 2019 08:01
Dublin investor presentation
September 23, 2019 07:00
Half-year Report
September 09, 2019 07:00
Notice of Results
August 08, 2019 07:00
Appointment of Head of Global Data
August 08, 2019 07:00
Trading update
July 08, 2019 07:00
Investment in data lake
June 17, 2019 07:00
Investor presentation
May 28, 2019 07:00
Holding(s) in Company
March 25, 2019 16:29
Holding(s) in Company
March 25, 2019 07:00
Second Price Monitoring Extn
March 21, 2019 14:05
Price Monitoring Extension
March 21, 2019 14:00
Admission to AIM & First Day of Dealings
March 21, 2019 07:00

Latest Investor News

Annual & Interim Reports

Diaceutics Corporate Overview Presentation, December 2025
Annual & Interim Reports

Annual Report and Financial Statements for the year ended 31 December 2024
News

PDMR Shareholding/Share Incentive Plan and Total Voting Rights
Articles

Register your Interest - Diaceutics PMx Capital Markets Webinar
Show More

Investor Alerts

If you would like to receive investor email alerts, simply complete this form. If you have already subscribed, you can change your settings or unsubscribe here.